|
Home >
About ACSH >
|
Gilbert Ross, M.D. > News Center
|
|
 |
 |
| [Hide Abstracts] |
 |
|
|
 |
|
|
 |
|
|
 |
|
|
 |
Guest opinion: Don't let money cloud the vision of drug regulators
By Gilbert Ross, M.D.
Publish Date : Monday, January 31, 2011
By Dr. Gilbert Ross. The medical journal Eye recently published a highly anticipated preliminary study comparing the drug Lucentis with the anti-cancer drug Avastin for the treatment of "wet," age-related macular degeneration (AMD). If Avastin is comparable in effectiveness to Lucentis, the federal government could see this as an opportunity to trim Medicare and Medicaid costs.
Read Full >>
|
 |
New Antibiotics, Stat! (National Review Online)
The vaccine makers are in a bind — and public health is in danger.
By Jonathan (Josh) Bloom, Ph.D., Gilbert Ross, M.D.
Publish Date : Monday, December 20, 2010
By Dr. Josh Bloom and Dr. Gilbert Ross.The development of new antibiotics has slowed to a trickle, just when we need them most. As drug-resistant bacteria are on the rampage worldwide, we find ourselves in a most precarious situation — one not unlike the one we faced in the pre-antibiotic era, before penicillin, when staphylococcal and pneumococcal infections were the dominant pathogens. . .
Read Full >>
|
 |
|
|
 |
|
|
 |
|
|
 |
|
|
 |
 |
| Total Records: 52 |
|
|
|
|
|